tm
Seeing Is Believing
tm
Seeing Is Believing
AVBP is currently covered by 4 analysts with an average price target of $46. This is a potential upside of $18.91 (36.74%) from yesterday's end of day stock price of $33.64.
ArriVent BioPharma, Common Stock's activity chart (see below) currently has 35 price targets and 34 ratings on display. The stock rating distribution of AVBP is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 31.47% with an average time for these price targets to be met of 117.62 days.
Highest price target for AVBP is $50, Lowest price target is $44, average price target is $46.
Most recent stock forecast was given by from CITI on 24-Apr-2026. First documented stock forecast 19-Feb-2024.
Currently out of the existing stock ratings of AVBP, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2024
$45
$11 (32.35%)
$33
2 months 20 days ago
(24-Apr-2026)
4/7 (57.14%)
$14.58 (47.93%)
198
Buy Since 20-Mar-2025
$45
$11 (32.35%)
$37
3 months 21 days ago
(23-Mar-2026)
0/2 (0%)
$22.82 (102.89%)
Buy Since 30-Apr-2024
$44
$10 (29.41%)
$42
4 months 8 days ago
(06-Mar-2026)
4/13 (30.77%)
$20.57 (87.79%)
94
Buy Since 15-Aug-2024
$50
$16 (47.06%)
$44
4 months 8 days ago
(06-Mar-2026)
1/6 (16.67%)
$26.57 (113.40%)
84
Buy Since 20-Feb-2024
$33
$-1 (-2.94%)
$38
1 years 4 days ago
(10-Jul-2025)
2/3 (66.67%)
$10.97 (49.80%)
259
What is AVBP (ArriVent BioPharma, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on AVBP (ArriVent BioPharma, Common Stock) with a proven track record?
Which analyst has the most public recommendations on AVBP (ArriVent BioPharma, Common Stock)?
Which analyst is the currently most bullish on AVBP (ArriVent BioPharma, Common Stock)?
Which analyst is the currently most reserved on AVBP (ArriVent BioPharma, Common Stock)?
